The goals of this study were to test the stability of two key regulatory enzymes, i.e., UGPase and VAcInv, as predictive selection markers for parent selection to obtain high frequency of clones with improved CIS resistance and to screen a large number of early generation clones. Here, UGP2 is linked to in situ carcinoma.